Keyphrases
Safety Self-efficacy
83%
Microbicides
83%
Innate Immunity
83%
Topical Microbicides
83%
Tenofovir
27%
Clinical Trials
27%
Acid pH
27%
Formulated Products
27%
Heterosexual Transmission
27%
Virus
27%
Complex Interactions
27%
HIV Status
27%
Host Defense
27%
Mode of Action
27%
Surrogate Marker
27%
Added Benefit
27%
HIV Transmission
27%
High-risk Women
27%
Molecular Umbrellas
27%
Therapeutic Approaches
27%
Mucosa
27%
Antiretroviral
27%
Natural Barrier
27%
Clinical Evaluation
27%
Cellulose Sulfate
27%
Inhibitory Activity
27%
CDK Inhibitors
27%
Sulfate Acid
5%
Medicine and Dentistry
Innate Immunity
100%
Microbicide
100%
Human Immunodeficiency Virus
83%
Clinical Trial
33%
Buffer
16%
Disease Marker
16%
Tenofovir
16%
Mucosa
16%
Host Resistance
16%
Infection
16%
Epileptic Absence
16%
Cellulose Sulfate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Microbicide
100%
HIV
83%
Clinical Trial
33%
Infection
16%
Disease Marker
16%
Buffer
16%
Tenofovir
16%
Cellulose Sulfate
16%
Epileptic Absence
16%